Literature DB >> 4105013

Use of practolol in asthmatics: a plea for caution.

L C Chang.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4105013     DOI: 10.1016/s0140-6736(71)91372-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  beta-Adrenoceptor antagonists and respiratory function.

Authors:  D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

2.  Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

Authors:  D G McDevitt
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

3.  Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?

Authors:  D G McDevitt
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

Review 4.  Adverse reactions and interactions with beta-adrenoceptor blocking drugs.

Authors:  R V Lewis; D G McDevitt
Journal:  Med Toxicol       Date:  1986 Sep-Oct

5.  Acute effect of indenolol on human airways.

Authors:  P Zanon; C Bruschi; I Cerveri; A Rossi; P Karitinos; F Pamparana
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 6.  Adverse effects of beta-adrenergic receptor blocking drugs on respiratory function.

Authors:  H M Beumer
Journal:  Drugs       Date:  1974       Impact factor: 9.546

7.  Metabolic and hormonal effects of preferential beta 1 and beta 2-adrenoceptor stimulation in man.

Authors:  C Tantucci; F Santeusanio; M Beschi; M Castellano; C Sorbini; V Grassi
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

Review 8.  Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  D W Harron; K L Goa; H D Langtry
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

9.  Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.

Authors:  R Fogari; A Zoppi; F Tettamanti; L Poletti; G Rizzardi; G Fiocchi
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 10.  Adverse reactions with beta-adrenoceptor blocking drugs. An update.

Authors:  R V Lewis; C Lofthouse
Journal:  Drug Saf       Date:  1993-10       Impact factor: 5.606

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.